Boundless Bio | 8-K: Current report
Boundless Bio | 8-K: Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results
Boundless Bio | 8-K: Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights
Boundless Bio | 8-K: Current report
Boundless Bio | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Boundless Bio, Inc. | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Boundless Bio, Inc. | S-1: General form for registration of securities under the Securities Act of 1933
No Data
No Data